180 / 464
180
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
POSTERS
> A predictive nomogram for decision support for patients with
pancreatic neuroendocrine tumours
A. Jochems, R. Baum (Germany), A. Singh, K. Niepsch, H. Kulkarni,
P. Lambin
PO-0696
> Reduced inter- and intra-observer variation in esophageal tumour
delineation using fiducial markers.
M. Machiels (The Netherlands), P. Jin, P. Jelvehgaran,
O.J. Gurney-Champion, E.D. Geijsen, P.M. Jeene, M.W. Kolff, V. Oppedijk,
M.B. Van Herk, T. Alderliesten, M.C.C.M. Hulshof
PO-0697
> Phase II study of induction chemotherapy followed by
radiochemotherapy in pancreatic cancer
M. Fiore (Italy), R. D’Angelillo, B. Floreno, P. Trecca, L. Trodella,
A. Iurato, L. Trodella, R. Coppola, S. Ramella
PO-0698
> Is stereotactic radiotherapy following radiochemotherapy useful in local
advanced pancreatic cancer?
G. Mattiucci, A. Nardangeli (Italy), L. Boldrini, M. Balducci, F. Cellini,
S. Chiesa, G. Chiloiro, F. Deodato, N. Dinapoli, V. Frascino,
M. Gambacorta, G. Macchia, A. Morganti, V. Valentini
PO-0699
> Significant heart dose reduction by deep inspiration breath hold for RT
of esophageal cancer
M. Dieters (The Netherlands), J.C. Beukema, A.C.M. Van den Bergh,
E.W. Korevaar, N.M. Sijtsema, J.A. Langendijk, C.T. Muijs
PO-0700
> Discrepancies between pathological data on nodal spread and the CTVs
in RT for biliary tract cancer
J. Socha (Poland), M. Michalak, G. Wołąkiewicz, L. Kępka
PO-0701
POSTER
Clinical track: Lower GI (colon, rectum, anus)
> Phase I trial evaluating panitumumab in combination with
chemoradiotherapy for anal cancers
V. Vendrely (France), C. Lemanski, E. Le Prise, E. Maillard, X. Mirabel,
G. Lledo, L. Dahan, A. Adenis, G. Paintaud, T. Lecomte, C. Levy-Piedbois,
E. Terrebonne, V. Mammar, S. Manfredi, T. Aparicio
PO-0702
> Bowel dysfunction resulting from different treatment strategies in
patients with rectal cancer.